The outlook revision is based on JRMC’s improved operating performance.
Moody’s also assigned a “Baa3” rating to JRMC’s $99 million of outstanding debt. The rating assignment is based on several factors, including JRMC’s adequate balance sheet cushion relative to debt structure risks.
More articles on healthcare finance:
Tenet reports lower-than-expected Q3 earnings
Pittsburgh Post-Gazette report has Pennsylvania reconsidering charity care definition
10 most-read healthcare finance stories in October
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
